13FINSIGHT
13F Insight
FilersStocks13FActivistsInsider
Login
FilersStocks13FActivistsInsiderResearchLearnNewsPricingTermsPrivacyContact

© 2026 13F Insight — Track smart money. Ask the AI Agent.

Listed on Turbo0Featured on Findly ToolsFeatured on toolfame.comFeatured on saasfame.comFeatured on Gets.ToolsZ-ImageFeatured On Micro SaaS ExamplesListed on MarketingDBFeatured on SaasDBFeatured on FazierBusiness Services - OnToplist.comFeatured on SubmitMySaasFeatured on ToolDirsFeatured on ToolfioFeatured on Twelve ToolsListed on uno directoryFeatured on Dang.aiFeatured on ToolPilotFeatured on Startup FameFeatured on PostmakeFeatured on Code.Market
13FINSIGHT
13F Insight
FilersStocks13FActivistsInsider
Login
  1. Home
  2. Insider Trading
  3. Schenkein David P

Schenkein David P

CIK: 0001578200
Director
Primary company: AGIOS PHARMACEUTICALS, INC. (AGIO)

Schenkein David P is a corporate insider at AGIOS PHARMACEUTICALS, INC. (AGIO) filing SEC Form 4 transactions. 338 transactions across 6 companies, totaling $99,960 in purchases and $67,683,825 in sales. Source: SEC EDGAR.

Total Transactions
338
Total Buy Value
$100K
Total Sell Value
$67.68M
Net Activity
$-67.58M
Last Transaction
Aug 2025
Companies
6

Companies

Transaction History

Source: SEC EDGAR Form 4 insider transaction filings.

Company
Type
Shares
Price
Value
Shares After
Date
SEC
Prime Medicine, Inc.
PRME
Award75,000$3.06$230K75,000
6/5/2026
Filed: 6/5/2026
Filing →
Denali Therapeutics Inc.
DNLI
Award19,226$19.66$378K19,226
6/3/2026
Filed: 6/3/2026
Filing →
Denali Therapeutics Inc.
DNLI
Award6,408--21,665
6/3/2026
Filed: 6/3/2026
Filing →
Prime Medicine, Inc.
PRME
Award45,000--45,000
8/1/2025
Filed: 8/5/2025
Filing →
Prime Medicine, Inc.
PRME
Disposition45,000--0
8/1/2025
Filed: 8/5/2025
Filing →
Prime Medicine, Inc.
PRME
Award39,062--39,062
8/1/2025
Filed: 8/5/2025
Filing →
Prime Medicine, Inc.
PRME
Disposition39,062--0
8/1/2025
Filed: 8/5/2025
Filing →
Prime Medicine, Inc.
PRME
Award55,000--55,000
6/4/2025
Filed: 6/5/2025
Filing →
Denali Therapeutics Inc.
DNLI
Award18,111--18,111
6/3/2025
Filed: 6/5/2025
Filing →
Denali Therapeutics Inc.
DNLI
Award6,037--15,257
6/3/2025
Filed: 6/5/2025
Filing →
REGENERON PHARMACEUTICALS, INC.
REGN
Award1,958$719.37$1.41M1,958
1/2/2025
Filed: 1/6/2025
Filing →
REGENERON PHARMACEUTICALS, INC.
REGN
Award166--448
1/2/2025
Filed: 1/6/2025
Filing →
Denali Therapeutics Inc.
DNLI
Exercise47,165--0
11/11/2024
Filed: 11/13/2024
Filing →
Denali Therapeutics Inc.
DNLI
Sale32,312$32.87$1.06M9,220
11/11/2024
Filed: 11/13/2024
Filing →
Denali Therapeutics Inc.
DNLI
Sale27,129$32.09$871K41,532
11/11/2024
Filed: 11/13/2024
Filing →
Denali Therapeutics Inc.
DNLI
Exercise47,165$18.00$849K68,661
11/11/2024
Filed: 11/13/2024
Filing →
AGIOS PHARMACEUTICALS, INC.
AGIO
Award11,774--11,774
6/20/2024
Filed: 6/24/2024
Filing →
AGIOS PHARMACEUTICALS, INC.
AGIO
Award2,120--2,120
6/20/2024
Filed: 6/24/2024
Filing →
AGIOS PHARMACEUTICALS, INC.
AGIO
Exercise3,388--0
6/13/2024
Filed: 6/17/2024
Filing →
AGIOS PHARMACEUTICALS, INC.
AGIO
Exercise3,388--126,242
6/13/2024
Filed: 6/17/2024
Filing →
Prime Medicine, Inc.
PRME
Type
Award
Shares
75,000
Price
$3.06
Value
$230K
Denali Therapeutics Inc.
DNLI
Type
Award
Shares
19,226
Price
$19.66
Value
$378K
Denali Therapeutics Inc.
DNLI
Type
Award
Shares
6,408
Price
-
Value
-
Prime Medicine, Inc.
PRME
Type
Award
Shares
45,000
Price
-
Value
-
Prime Medicine, Inc.
PRME
Type
Disposition
Shares
45,000
Price
-
Value
-
Prime Medicine, Inc.
PRME
Type
Award
Shares
39,062
Price
-
Value
-
Prime Medicine, Inc.
PRME
Type
Disposition
Shares
39,062
Price
-
Value
-
Prime Medicine, Inc.
PRME
Type
Award
Shares
55,000
Price
-
Value
-
Denali Therapeutics Inc.
DNLI
Type
Award
Shares
18,111
Price
-
Value
-
Denali Therapeutics Inc.
DNLI
Type
Award
Shares
6,037
Price
-
Value
-
REGENERON PHARMACEUTICALS, INC.
REGN
Type
Award
Shares
1,958
Price
$719.37
Value
$1.41M
REGENERON PHARMACEUTICALS, INC.
REGN
Type
Award
Shares
166
Price
-
Value
-
Denali Therapeutics Inc.
DNLI
Type
Exercise
Shares
47,165
Price
-
Value
-
Denali Therapeutics Inc.
DNLI
Type
Sale
Shares
32,312
Price
$32.87
Value
$1.06M
Denali Therapeutics Inc.
DNLI
Type
Sale
Shares
27,129
Price
$32.09
Value
$871K
Denali Therapeutics Inc.
DNLI
Type
Exercise
Shares
47,165
Price
$18.00
Value
$849K
AGIOS PHARMACEUTICALS, INC.
AGIO
Type
Award
Shares
11,774
Price
-
Value
-
AGIOS PHARMACEUTICALS, INC.
AGIO
Type
Award
Shares
2,120
Price
-
Value
-
AGIOS PHARMACEUTICALS, INC.
AGIO
Type
Exercise
Shares
3,388
Price
-
Value
-
AGIOS PHARMACEUTICALS, INC.
AGIO
Type
Exercise
Shares
3,388
Price
-
Value
-
...
AI Agent

Try asking...

FilersStocks13FActivistsInsiderResearchLearnNewsPricingTermsPrivacyContact

© 2026 13F Insight — Track smart money. Ask the AI Agent.

Listed on Turbo0Featured on Findly ToolsFeatured on toolfame.comFeatured on saasfame.comFeatured on Gets.ToolsZ-ImageFeatured On Micro SaaS ExamplesListed on MarketingDBFeatured on SaasDBFeatured on FazierBusiness Services - OnToplist.comFeatured on SubmitMySaasFeatured on ToolDirsFeatured on ToolfioFeatured on Twelve ToolsListed on uno directoryFeatured on Dang.aiFeatured on ToolPilotFeatured on Startup FameFeatured on PostmakeFeatured on Code.Market